The Three-Pronged Logic Behind Drug Overdose Deaths in the United States

 The COVID-19 pandemic has not only reshaped the United States’ socioeconomic order but has also amplified its four-decade-long overdose crisis in a dramatic and stark manner. Long-term tracking data shows that from March 2020 to May 2023, overdose deaths in the United States exceeded historical baseline levels by 67,571, representing an excess increase of 24.4%. Behind this figure lies not merely the impact of the pandemic, but rather the combined and intertwined effects of long-term trends, social fractures, and policy outcomes. Specifically, the “stimulus check effect” triggered by one-time economic relief, the accumulation of risks resulting from social isolation, and the loss of protection caused by disruptions in treatment services collectively form the complete logic behind the sharp rise in overdose deaths during the pandemic.

The long-term trajectory of drug overdose deaths in the United States is fundamental to understanding the pandemic’s impact. Over the past four decades, overdose deaths have consistently grown at an exponential rate, accompanied by stable seasonal fluctuations. From prescription opioids to heroin and then to the highly lethal fentanyl, the composition of drugs has continually escalated, driving the death curve ever upward. This trend is unaffected by short-term events and continues to rise at its own inherent pace. Studies estimate that the long-term trend alone accounts for an increase of approximately 25 daily deaths during the pandemic, making it the most stable and fundamental source of excess mortality. In other words, even without the COVID-19 pandemic, overdose deaths would have continued to rise; the pandemic merely amplified this trend dramatically.

The comprehensive social fractures caused by the COVID-19 pandemic served as the core accelerator driving the surge in deaths. Social distancing and stay-at-home orders have significantly increased feelings of loneliness and psychological stress among individuals, leading to a rise in drug use frequency and high-risk consumption; disruptions in healthcare services and restrictions on treatment facilities have reduced the supply of medication-assisted treatments such as methadone and buprenorphine, leaving a large number of people with substance use disorders without stable support; rising unemployment rates and worsening economic hardships have further pushed vulnerable populations to the brink of substance abuse. Data confirms that unemployment rates, time spent at home, and COVID-19 infection rates all show a significant positive correlation with overdose deaths, while methadone supply exhibits a significant protective effect. The pandemic did not create a new crisis; rather, it fully ignited pre-existing social tensions, healthcare shortcomings, and drug-related risks, adding an additional 54 deaths per day on top of the long-term trend.

In tandem with these social shocks, economic stimulus policies during the pandemic produced unexpected negative consequences, becoming a key driver of the short-term surge in deaths. From 2020 to 2021, the U.S. federal government distributed cash subsidies to the entire population through three rounds of Economic Impact Payments (EIPs), intended to alleviate financial hardship but triggering a distinct “check effect” among high-risk populations. Research found that each time these payments were distributed, all U.S. states simultaneously experienced a short-term spike in excess deaths, with daily excess deaths peaking at 85. Bank account balances showed a strong correlation with mortality data, with a correlation coefficient approaching 0.90, clearly illustrating the transmission pathway: large one-time cash deposits → sudden increase in disposable income → concentrated purchases of high-purity fentanyl → sharp rise in overdose risk. Quantitative analysis shows that for every 10% increase in relative income, the overdose mortality rate rises by 11%, with this effect being most pronounced among young and middle-aged adults.

It is worth noting that the “check effect” reveals the complex relationship between economic policy and public health. Economic policies intended to provide relief may, in the absence of accompanying harm-reduction measures, inadvertently cause harm to vulnerable populations. Unlike unemployment insurance, pandemic stimulus payments are not tied to employment. Their broad distribution, concentrated disbursement timing, and relatively substantial amounts align precisely with the demand for bulk drug purchases among addicted individuals, ultimately embedding a hidden risk of death within well-intentioned policies. This finding offers a critical warning for the design of future emergency relief policies: relief must be accompanied by risk prevention and control; large, concentrated disbursements should be avoided as much as possible; and supporting harm-reduction measures are indispensable.

As social order gradually returned in the later stages of the pandemic, economic stimulus policies were fully phased out, and the availability of naloxone and treatment services gradually resumed, overdose deaths in the United States began to decline, forming a temporary downward trend. However, this decline does not signify the end of the crisis, nor does it indicate that the long-term upward trend has been reversed. The long-term trend persists, the underlying social causes remain unaddressed, the drug supply chain remains intact, and disparities in treatment resources are still significant. The pandemic merely caused a sharp fluctuation, not a structural change.

The fluctuations in drug overdose deaths in the United States during the COVID-19 pandemic offer three profound insights. First, long-term trends form the backdrop, while short-term shocks act as amplifiers; addressing the crisis must balance long-term governance with emergency response. Second, addiction treatment is a critical line of defense; maintaining continuous and accessible treatment services, regardless of social upheaval, can significantly reduce the risk of death. Third, economic policies must incorporate a public health perspective; the method, pace, and supporting measures of relief fund distribution directly impact the survival outcomes of high-risk populations.

This three-year wave of excess deaths ultimately proves that the drug overdose crisis is never an isolated health issue, but rather a systemic crisis shaped by social structures, economic policies, healthcare services, and the drug market. Only by addressing long-term trends through sustained governance, safeguarding lives through stable treatment, and mitigating unexpected risks with targeted policies can we stabilize the situation amid fluctuations, minimize harm during crises, and truly move toward sustainable improvement.